Core Viewpoint - Ningbo Huaxiang (002048.SZ) has signed a contract with a leading domestic robot joint manufacturer to produce robot joint products over the next two years, which will enhance its competitive advantage in the smart robot components market [1] Group 1: Contract Details - The contract was signed on December 23, 2025, between Ningbo Huaxiang's subsidiary, Ningbo Huaxiang Qiyuan Technology Co., Ltd. (referred to as "Huaxiang Qiyuan"), and a major domestic robot joint manufacturer [1] - Huaxiang Qiyuan will manufacture certain robot joint products to meet the market demand of the client [1] Group 2: Strategic Implications - This collaboration is expected to help Huaxiang Qiyuan build a differentiated competitive advantage in its smart robot component product matrix [1] - The partnership lays a solid foundation for developing core joint components based on PEEK materials, promoting the rapid implementation of the company's emerging industry strategy [1] Group 3: Financial Impact - The current year's operating performance will not be significantly affected by this contract [1] - Starting from January 2026, the bulk supply to the client is anticipated to positively impact the company's future operating performance [1]

人民财讯12月23日电，宁波华翔（002048）12月23日公告，公司下属子公司——宁波华翔启源科技有限 公司12月23日与国内某头部机器人关节厂商签订《机器人关节委托生产合同》，华翔启源将在未来两年 内为其生产制造部分机器人关节产品。随着2026年1月启动客户批量供货，该事项将对公司未来经营业 绩产生积极影响。 ...

Core Viewpoint - Ningbo Huaxiang announced that its subsidiary Huaxiang Qiyuan signed a contract for the entrusted production of robot joints with a leading domestic robot joint manufacturer, which will enhance its product matrix in smart robot components and support the implementation of its emerging industry strategy [1] Group 1 - The contract is set to commence on December 23, 2025, and will involve Huaxiang Qiyuan producing certain robot joint products for the next two years [1] - The collaboration is expected to have a minimal impact on the company's operating performance for the current year, but will positively influence future performance starting from January 2026 when bulk supply begins [1]

董事会公告 宁波华翔电子股份有限公司 关于子公司获得机器人关节订单的公告 本公司全体董事、监事、高级管理人员保证公告内容真实、准确和完整，并对公告 中的虚假记载、误导性陈述或者重大遗漏承担责任。 本公司下属子公司——宁波华翔启源科技有限公司（以下简称"华翔启源"）于 2025 年 12 月 23 日与国内某头部机器人关节厂商（以下简称"客户"）签订了《机器人关节委 托生产合同》，基于双方资产、团队及其他资源，华翔启源将在未来两年内为其生产制造 部分机器人关节产品，以满足其市场需求。公司将按照客户要求，在规定的时间内完成 上述产品的生产制造。 本次合作是有利于华翔启源打造有差异化竞争优势的智能机器人零部件产品矩阵， 为开发基于 PEEK 材料的核心关节件打下坚实基础，推动公司新兴产业战略的快速落地。 该事项对公司本年度的经营业绩不会产生较大影响，随着 2026 年 1 月启动客户批量 供货，将对公司未来经营业绩产生积极影响。敬请广大投资者注意投资风险。 特此公告。 股票代码：002048 股票简称：宁波华翔 公告编号：2025-085 宁波华翔电子股份有限公司 董事会 2025 年 12 月 24 日 1 ...

Group 1 - Xusheng Group's actual controller has changed to the Guangzhou Municipal Government, with stock resuming trading on December 23, 2025 [1] - Lingyun Light plans to invest up to $5 million in the IPO of Zhipu Hong Kong as a cornerstone investor [1] - Ningbo Huaxiang's subsidiary has signed a strategic cooperation agreement with Dahuan Robotics to enhance collaboration in the development of dexterous hands [2] Group 2 - Hualian Holdings intends to acquire 100% of the Canadian company Argentum Lithium S.A. for $175 million, which is approximately 1.235 billion yuan [3] - Shiyuan Zhaoye plans to raise no more than 550 million yuan through a convertible bond issuance for the Zhuhai Shiyuan Jingguan Garden project [4] - ST Quanwei and its subsidiary are involved in a civil mediation agreement involving 69.0158 million yuan [4] Group 3 - Jiao Jian Co.'s actual controller has been subjected to criminal coercive measures, but the company's control has not changed [5] - Tianji Technology is facing a lawsuit for alleged collusion in bidding, but its operations remain normal [5] - Jinpan Technology plans to issue 1.672 billion yuan in convertible bonds for data center power modules and other projects [5] Group 4 - Hongqi Chain's shareholder Yonghui Supermarket plans to reduce its stake by up to 3% [6] - Shuangqiang Technology's director did not implement a planned share reduction [7] - Zhuoran Co.'s subsidiary has signed a significant order worth 4.033 billion yuan [8] Group 5 - ST Zhitong's stock will have its risk warning lifted on December 24, 2025, with a change in trading limits [9] - Yingwei Co. plans to reduce its stake by up to 0.56% [10] - Huaxia Happiness's board rejected five temporary proposals from China Ping An Life Insurance [11] Group 6 - China Nonferrous Metals plans to acquire 99.9% of Raura Company for $106 million [11] - Sanhua Intelligent Control expects a net profit of 3.874 billion to 4.649 billion yuan for 2025, a year-on-year increase of 25% to 50% [11] - Chaoxun Communication received a government subsidy of 18.0455 million yuan [12] Group 7 - Jiangfeng Electronics plans to transfer 4% of Shanghai Runping's equity for 60 million yuan [12] - Dingyang Technology has launched a 20 GHz high-bandwidth digital oscilloscope [13] - Linyi Intelligent plans to acquire 35% of Dongguan Liminda Electronics for 875 million yuan [14] Group 8 - Trina Solar has sold its U.S. 5GW module factory to T1, receiving $100 million in cash and shares [14] - Aihua Packaging's major shareholder reduced its stake by 700,000 shares during the stock's abnormal fluctuation period [14] - China Merchants Bank has approved a comprehensive credit limit of 165 billion yuan for China Merchants Group [15] Group 9 - Lingwei Technology plans to acquire 70% of Jiangsu Huimai for 50.2 million yuan [16] - Yongding Co. is increasing its capital by 600 million yuan for its polysilicon subsidiary [19] - Zhong'an Technology's subsidiary is voluntarily extending its share lock-up period by six months [19] Group 10 - Xiangyu Medical's brain-computer interface products have entered over 500 top-tier hospitals, with a target of 700 by the Spring Festival [18] - Wenda Technology's major shareholder has terminated its share reduction plan [18] - Wenta Technology's major shareholder reduced its stake by 1.2097 million shares [18]

Core Viewpoint - Ningbo Huaxiang announced a strategic cooperation agreement with Shenzhen Dahuan Robot Technology to enhance collaboration in the research, manufacturing, and sales of general humanoid robot dexterous hands [1] Group 1 - Ningbo Huaxiang's subsidiary, Ningbo Huaxiang Qiyuan Technology Co., Ltd., is involved in the partnership [1] - The collaboration focuses on the development of humanoid robot technology, which is a growing sector in the robotics industry [1]

Group 1 - Tongyu Communication's subsidiary Zhonghong Tongyu plans to introduce Wuhan Wuchuang Institute as an investor through a capital increase of 10 million yuan, raising its registered capital from 200 million yuan to 210 million yuan, and reducing Tongyu's shareholding from 90% to 85.7143% [1] - Sanli Pharmaceutical signed a technology transfer contract with Hainan University to acquire the patent rights for the HXW2324 compound, aimed at developing new Alzheimer's disease treatments, for a total price of 200 million yuan [2] - Ningbo Huaxiang's subsidiary signed a strategic cooperation agreement with Shenzhen Dahuang Robot Technology to enhance collaboration in the development and manufacturing of general humanoid robot dexterous hands [3] Group 2 - Dook Culture announced a potential change in control, leading to a temporary suspension of its stock trading starting December 22, 2025, to ensure fair information disclosure [4] - Nanya New Materials plans to raise no more than 900 million yuan through a private placement to fund AI-based high-frequency copper-clad laminate projects and supplement working capital [5] - Hexing Packaging's major shareholder reduced their stake by 700,000 shares during a period of stock price volatility, consistent with previously disclosed plans [6] Group 3 - Yongding Co. plans to increase capital and introduce external investors, including Cambridge Technology, with a total cash increase of 55 million yuan, resulting in a decrease in its shareholding in Dingxin Optoelectronics [7] - ChaoSheng Electronics intends to invest 1 billion yuan in a high-performance HDI printed circuit board expansion and upgrade project, expecting to add an annual production capacity of 240,000 square meters [8] - Lingyi ZhiZao signed an agreement to acquire 35% of the shares of Limin Da for 875 million yuan, gaining control over 52.78% of the voting rights in the company [10] Group 4 - Sanhua Intelligent Control forecasts a net profit of 3.874 billion to 4.649 billion yuan for 2025, representing a year-on-year growth of 25% to 50% [11] - Aolian Electronics announced a potential change in control due to the planned transfer of shares by its major shareholder, leading to a temporary stock suspension starting December 22, 2025 [12]

Group 1 - Rongchang Biotech plans to repurchase shares worth between 20 million and 40 million yuan, with a maximum price of 95 yuan per share, aiming to buy back approximately 21,050 to 42,110 shares, representing about 0.04% to 0.07% of total share capital [1] - Nanya New Materials intends to raise no more than 900 million yuan through a private placement for AI computing power-based high-frequency high-speed copper-clad laminate R&D and working capital [2] - Xiechuang Data has signed a strategic cooperation agreement with Ping An Financial Leasing, aiming for a cooperation scale of 2 billion yuan over three years [3] Group 2 - Chuangshi Technology's controlling shareholder is under investigation and has been placed under detention, having resigned from all positions in the company [4] - Deep Kangjia A has reported overdue shareholder loans to Yikang Technology and Chuzhou Kangxin, totaling approximately 233 million yuan and 395 million yuan respectively, due to repayment issues [5] - Ningbo Yuanyang announced the resignation of two directors due to work adjustments [6] Group 3 - China Merchants Energy has delivered the world's first methanol dual-fuel VLCC oil tanker, with 15 oil tanker orders in hand [7] - Tianyu Co., Ltd. has received a drug registration certificate for hydrochloride trazodone tablets, which are used for treating depression [8] - Haizheng Pharmaceutical has received FDA approval for clinical trials of HS387 tablets for treating advanced solid tumors [9] Group 4 - Warner Pharmaceuticals has obtained a drug registration certificate for isoproterenol hydrochloride injection, used for treating shock and complete atrioventricular block [10] - Hekang New Energy's subsidiary received a government subsidy of 1.5 million yuan, which accounts for 14.57% of the company's latest audited net profit [11] - Duku Culture is planning a change in company control, with stock suspension expected for no more than two trading days [12] Group 5 - Haisco has received acceptance for an IND application for HSK46575 tablets for prostate cancer treatment [13] - *ST Xinyan is executing a capital reserve transfer to increase share capital, resulting in a stock suspension [14] - Nanjing Public Utilities is transferring a 45% stake in a subsidiary for 23.6443 million yuan [15] Group 6 - Action Education plans to repurchase shares worth between 20 million and 25 million yuan, with a maximum price of 45 yuan per share [16] - Bai'ao Tai has received government subsidies totaling 29 million yuan [18] - Weisi Medical intends to sell assets worth 119 million yuan, expecting a profit impact of approximately 10 million yuan [19] Group 7 - Tongyu Communications plans to increase capital by 10 million yuan to introduce investment from Wuchuang Institute [20] - Dongtu Technology's subsidiary is introducing strategic investor Guofeng Investment Fund with a capital increase of 11 million yuan [21] - China General Nuclear Power Technology's shareholder is facing a judicial auction of 2.91% of the company's shares [22] Group 8 - Nanshan Aluminum plans to repurchase shares worth between 300 million and 600 million yuan, with a maximum price of 7.52 yuan per share [23] - Yipin Hong's controlling shareholder has committed to transferring 9.07% equity in Arthrosi without compensation [24] - Sanli Pharmaceutical has signed a technology transfer contract worth 200 million yuan with Hainan University [25] Group 9 - Xin Nuo Wei plans to jointly invest 450 million yuan with Zhongqi Pharmaceutical to establish a joint venture focusing on innovative metabolic drugs [26] - Li Qun Co. has been approved to issue 1 billion yuan in medium-term notes to optimize debt structure and supplement working capital [27] - Dongfang Ocean's subsidiary has received a medical device registration certificate for a procalcitonin test kit [28] Group 10 - Tibet Mining's chairman has resigned due to work adjustments [29] - Wantai Biological's subsidiary has been shortlisted for a national immunization program vaccine procurement project, with a bid price of 27.5 yuan [30] - Xingfu Blue Sea has appointed Zhang Chen as the new deputy general manager [31] Group 11 - Changyuan Donggu has elected Li Yixuan as the vice chairman of the board [32] - Ningbo Huaxiang's subsidiary has signed a strategic cooperation agreement with Dahuang Robotics for collaboration in humanoid robot development [33] - Yongda Co. has been pre-selected for a procurement project worth approximately 350 million yuan [34] Group 12 - Fuan Pharmaceutical's subsidiary has received a drug registration certificate for hydrochloride trazodone tablets [35] - Nanjing Food reported a 71.03% year-on-year decrease in net profit for November due to rising raw material costs [36] - Changqing Technology's special polymer monomer project has commenced production [37]

Core Viewpoint - Ningbo Huaxiang's subsidiary, Huaxiang Qiyuan, has signed a strategic cooperation agreement with Shenzhen Dahuan Robot Technology to enhance the development and manufacturing of general-purpose humanoid robot dexterous hands, aiming to drive innovation in the robot supply chain and product development [1][2]. Group 1: Strategic Cooperation - The cooperation focuses on the development and mass production of a specific six-degree-of-freedom dexterous hand product, with Dahuan Robot responsible for product design and development verification, while Huaxiang Qiyuan handles solution confirmation, mass assembly, and sales to clients [1]. - This agreement is seen as a strategic extension of Huaxiang Qiyuan's main business, which will not alter the company's core operations or independence [2]. Group 2: Company Background and Future Outlook - Ningbo Huaxiang primarily engages in the design, development, production, and sales of automotive parts, serving major automotive manufacturers such as Volkswagen, Mercedes-Benz, BMW, and various domestic electric vehicle makers [2]. - The strategic partnership is expected to deepen the construction of the robot industry chain and accelerate the realization of Huaxiang Qiyuan's vision to become a "hardware manufacturing solution service provider" [2]. - The company plans to leverage its advanced manufacturing experience in the automotive parts sector to participate in the embodied intelligent robot industry chain, which may enhance operational efficiency and optimize cost structures in the long term [3].

Core Viewpoint - Ningbo Huaxiang (002048.SZ) has signed a strategic cooperation agreement with Shenzhen Dahuang Robot Technology Co., Ltd. to accelerate the development of the general robotics industry and enhance product innovation and supply chain demonstration in the field of general humanoid robot dexterous hands [1] Group 1: Strategic Cooperation - The agreement aims to strengthen collaboration in the research, manufacturing, and sales of general humanoid robot dexterous hands [1] - Both parties will focus on the development and mass production of a specific six-degree-of-freedom dexterous hand product based on the needs of Party A and its clients [1] Group 2: Responsibilities - Party B (Dahuang Robot) is responsible for product design and development validation, as well as the servo cylinder module [1] - Party A (Huaxiang) will handle the confirmation of the dexterous hand solution, mass assembly, and sales to Party A's clients [1]